Skip to main content
Caplight Logo









Ensocell

Ensocell

Private
CambridgeHealthcare & Life Scienceshttps://www.ensocell.com/

Last Round

Seed

May 7, 2024

Total Funding Raised

$16.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ensocell is a biotechnology company that utilizes single-cell genomics and AI-based computational tools to discover precision biologics for autoimmune, inflammatory, and fibrotic diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoveryprecision medicineAI drug discoveryin silico drug discoverysingle-cell genomicsspatial genomicstarget identificationbiotechnologybiologicscomputational biologyautoimmune disease researchfibrotic disease researchdrug pipelinebiotech platformAI-driven R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ensocell Comparables

Compare Ensocell with similar companies based on industry and business-model similarity.

Ensocell comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Scailyte AG
80%
CytoReason
77%
Immunai
77%

Ensocell Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 7, 2024

Ensocell Investors

Notable investors and investment history

Ensocell investors
InvestorRounds
OMX VenturesSeed
Sofinnova PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Grew 21% QoQ, from 19 to 23 employees.

  • Apr 24, 2026

    Monthly visitors grew 103% MoM, reaching 1.8K.

Ensocell Filings

Explore SEC and related filing metadata, where available.

Ensocell filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ensocell's valuation, stock price, and market status.

Is Ensocell a public or private company?

Ensocell is a private company.

What is the current stock price of Ensocell?

Ensocell is a private company with no public stock price. No recent secondary market data is available.

How much is Ensocell worth (valuation)?

Valuation information for Ensocell is not publicly available.

Can I buy Ensocell stock?

Ensocell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ensocell's last funding round?

Ensocell's most recent funding round was Seed on May 7, 2024.

Who are the main investors in Ensocell?

Key investors in Ensocell include OMX Ventures, Sofinnova Partners.

Will Ensocell IPO soon?

No public IPO plans have been announced for Ensocell.

How can I track Ensocell secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ensocell's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range23
Year Founded2023
Last FundingMay 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?